Target intelligence / Profile preview

Mesenchymal–epithelial transition (MET)

Target
MET
Molecular classification
Other (biological process, not a molecule or receptor)
01

Overview

Mesenchymal–epithelial transition (MET) is a reversible biological process, not a single molecule or receptor. It involves the transformation of motile, spindle-shaped mesenchymal cells into organized arrays of polarized epithelial cells. This transition is crucial during embryonic development for forming tissues and organs—such as during kidney formation where nephrogenic mesenchyme undergoes MET to form renal epithelium[4][7]. The reverse process is called epithelial–mesenchymal transition (EMT) and both processes are essential for normal development, wound healing, tissue regeneration, cancer progression/metastasis reversal, and cellular reprogramming[4][5][6]. MET does not refer to a specific protein or gene but describes coordinated changes in gene expression—upregulation of epithelial genes like E-cadherin and downregulation of mesenchymal genes such as vimentin or N-cadherin[4][7]. While some oncogenic proteins are named similarly—for example "mesenchymal epithelial transition factor" (MET, also known as c-Met), which is an actual receptor tyrosine kinase—the term "mesenchymal–epithelial transition" refers only to the cellular state change/process. Because it is not an individual molecular entity, but rather a complex physiological event involving many signaling pathways and transcription factors (e.g., Snail family), it should not be considered a direct therapeutic target like receptors or enzymes, though its regulation can be therapeutically relevant in cancer biology[4][5]. “A mesenchymal–epithelial transition (MET) is a reversible biological process that involves the transition from motile...mesenchymal cells to planar arrays of polarized cells called epithelia. MET...has been shown to occur in normal development...cancer metastasis and wound healing.”[4] If you intended information about the *receptor tyrosine kinase* commonly abbreviated "MET" ("hepatocyte growth factor receptor"), please clarify your query.

Other names
METMesenchymal to epithelial transition
02

Biological functions

Cell differentiationTissue morphogenesisEmbryonic developmentCellular reprogramming (including induced pluripotent stem cell generation)Cancer metastasis reversalWound healing
03

Disease associations

Cancer (especially in the context of metastasis and tumor progression)Organ fibrosisDevelopmental disorders
04

Biomarkers

Markers associated with MET include increased expression of epithelial markers such as E-cadherin and decreased expression of mesenchymal markers like vimentin, N-cadherin, fibronectin, Twist, and Snail

Beyond the preview

Go deeper on Mesenchymal–epithelial transition (MET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesenchymal–epithelial transition (MET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call